Where VA and federal policy stands on CBD

Chronic pain

• NIH's National Center for Complementary and Integrative Health (NCCIH) describes a 2018 review of 47 studies. It found a small benefit: 29% of people taking cannabinoids had at least a 30% reduction in pain, compared with 26% of people taking a placebo. NCCIH says the difference may not be meaningful to patients, and side effects were more common with cannabinoids. That finding covers cannabinoids as a group, not CBD products sold online specifically.
• In a 2019 news release, NCCIH said research support for CBD and pain is weak, even though products like CBD are widely assumed to be safe and effective for pain. It announced nine research grants, about $3 million in total, to study minor cannabinoids and terpenes for pain.

Federal position: federal scientists describe the evidence as weak, and NIH is funding more research.

Sources: NIH NCCIH: Cannabis (Marijuana) and Cannabinoids: What You Need To Know (2019); NIH NCCIH news release on cannabinoid pain research (Sept. 19, 2019).

PTSD

• The 2023 VA/DoD Clinical Practice Guideline for PTSD gives a strong recommendation against using cannabis or cannabis-derived products to treat PTSD. The guideline does not single out CBD by name.
• VA's National Center for PTSD says cannabis is not supported as an effective PTSD treatment. A review of 14 studies did not support cannabis for overall PTSD symptoms. Many veterans say it helps, but that belief rests mainly on personal accounts.
• The same VA page says early studies suggest oral CBD may reduce anxiety and that CBD treatments are being tested for social anxiety and PTSD. It also says research on FDA-approved cannabis-based medicines can't be applied to whole-plant or commercial products.
• The Center says cannabis use can make PTSD treatment less effective and raise the chance of dropping out. Those findings are about cannabis use in general, not CBD alone.
• A study by clinicians at the Battle Creek VA Medical Center reviewed the charts of 340 veterans in a PTSD treatment program. Success rates were nearly the same for veterans who used cannabis (51.9%) and those who did not (51.4%). The study did not look at CBD separately, and the authors note its limits, including that it was a chart review at a single site.

Federal numbers

Numbers from VA's National Center for PTSD (updated Sept. 3, 2025).

Federal position: the VA and DoD recommend against cannabis-based treatment for PTSD. Proven treatments exist, and the Get help page shows where to start.

Sources: VA/DoD PTSD Clinical Practice Guideline, Quick Reference (v4.0, 2023); VA National Center for PTSD: Cannabis Use and PTSD Among Veterans (updated Sept. 3, 2025); Petersen et al., Effect of cannabis use on PTSD treatment outcomes in veterans, The Mental Health Clinician, 2021.

Anxiety

• NCCIH says evidence is limited. In one study of 24 people with social anxiety, people felt less anxiety during a simulated public-speaking test after taking CBD than after a placebo.
• VA's National Center for PTSD says early studies suggest oral CBD may reduce anxiety, and that it is being tested for social anxiety and PTSD.

Federal position: early and small studies, not yet enough to say CBD works for anxiety.

Sources: NIH NCCIH: Cannabis (Marijuana) and Cannabinoids: What You Need To Know (2019); VA National Center for PTSD: Cannabis Use and PTSD Among Veterans (updated Sept. 3, 2025).

Sleep

• NCCIH says many studies report better sleep quality with cannabis-based products, but it's unclear whether the products directly improved sleep or whether symptoms of an underlying illness improved. Effects in people without other illnesses are uncertain.

Federal position: unclear. Poor sleep that lasts is worth raising with a provider.

Source: NIH NCCIH: Cannabis (Marijuana) and Cannabinoids: What You Need To Know (2019).

General wellness

• FDA has approved one CBD product, the prescription drug Epidiolex (approved in 2018), for seizures linked to certain rare conditions in people age one and older. It has approved no other CBD products.
• FDA says other CBD products have not been evaluated for effectiveness, dosing, interactions or side effects. Its testing found that many contained less CBD than their labels said, and it is investigating reports of contaminants such as pesticides, heavy metals and THC.
• FDA has warned companies about CBD claims for serious conditions, including psychiatric disorders, and says such claims can lead people to delay proper care.
• We did not find a U.S. government source saying that CBD products improve general health or wellness.

Federal position: no federal source supports general wellness claims for CBD.

Sources: FDA: What You Need to Know (and What We're Working to Find Out) About Products Containing Cannabis or Cannabis-Derived Compounds, Including CBD; FTC: Serious health claims for CBD products need proof.